Feed aggregator

Mississippi man is suing a funeral home for refusing to cremate his husband

Pharma news - May 3, 2017 - 4:38am

For most of the 52 years he was in a relationship with Robert Huskey, Jack Zawadski doesn’t remember much in the way of anti-gay discrimination. Not even when they moved to Mississippi 20 years ago to retire someplace warmer and more lush, or after they married in 2015, when the Supreme Court declared that gay couples have as much of a right as heterosexuals to marry. In a response filed with the court in March, the owners of the Picayune Funeral Home in Picayune, Miss., deny the events as described by Zawadski and his nephew, who made the arrangements and is co-plaintiff.


Categories: Pharma News

iPhone 8 Delayed Until 2018?

Pharma news - May 3, 2017 - 4:33am

Several reports have come out suggesting that Apple will be delaying the release of iPhone 8, while the iPhone 7s and iPhone 7s Plus are on track to be out by September.


Categories: Pharma News

Trump Welcomes Palestinian President, Offers to Mediate Peace Process

Pharma news - May 3, 2017 - 4:16am

During a joint press conference, President Trump tells Palestinian President Mahmoud Abbas that an peace agreement with Israel “cannot be imposed by the United States or by any other nation.”


Categories: Pharma News

UK will not pay 100 billion euro EU exit bill, says Brexit minister

Pharma news - May 3, 2017 - 3:43am

Britain will not be paying 100 billion euros ($109.14 billion) to leave the European Union, Brexit minister David Davis said on Wednesday after the Financial Times reported that the EU was preparing to demand that amount. The FT said that after requests from member states, EU negotiators had revised their initial calculations to maximise the liabilities Britain would be asked to cover, including post-Brexit farm payments and EU administration fees in 2019 and 2020.


Categories: Pharma News

All aboard: luxury Japanese train has bath and fireplace

Pharma news - May 3, 2017 - 3:38am

It's got Michelin-starred chefs, solid cypress bathtubs and a cosy snug complete with roaring fire: the Shiki-Shima could hold its own against any five-star hotel. In a country best known for its super-fast "Shinkansen" bullet trains, the emphasis in Japan's latest extravaganza on rails is on savouring the moment, with no expense spared to create the most luxurious travelling experience. After dinner they can gather for a drink around the piano, or sit and soak up the atmosphere next to the fireplace -- actually a trick created by steam and coloured light -- on a journey that takes them from Tokyo to the northernmost island of Hokkaido and back again.


Categories: Pharma News

AstraZeneca boosts early respiratory medicine with Pieris deal

Reuters Health News - May 3, 2017 - 2:40am
LONDON (Reuters) - AstraZeneca boosted its early-stage respiratory medicine pipeline on Wednesday by signing a deal with Pieris Pharmaceuticals to develop novel inhaled drugs that could fight asthma in new ways.
Categories: Consumer Health News

Carmat buoyed by approval to resume artificial heart trial

Reuters Health News - May 3, 2017 - 2:33am
(Reuters) - Artificial heart maker Carmat has obtained approval from France's national drugs agency (ANSM) to resume a heart implant trial, sending the company's shares more than one fifth higher on Wednesday.
Categories: Consumer Health News

Iran's reformist ex-president backs Rouhani reelection

Pharma news - May 3, 2017 - 2:14am

Iran's reformist former president Mohammad Khatami has skirted a media ban to endorse moderate incumbent Hassan Rouhani for a second term over conservative challengers in a tight May 19 election. Khatami, who during his 1997-2005 presidency oversaw a rapprochement with the West, has been barred from speaking openly since mass protests against the disputed reelection of his hardline successor Mahmoud Ahmadinejad in 2009. The hardliner's replacement by Rouhani in 2013 has seen a nuclear deal between Iran and world powers that led to the lifting of most international economic sanctions but is threatened by a tougher stance from the new US administration of Donald Trump.


Categories: Pharma News
Syndicate content